Core Viewpoint - The company, Shantou Ultrasonic Instrument Research Institute Co., Ltd., is engaged in the research, development, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, with a focus on the pet economy and smart medical technology [2][3][7]. Group 1: Company Overview - Shantou Ultrasonic Instrument Research Institute Co., Ltd. was established on November 15, 1982, and was listed on January 22, 2025 [7]. - The company's main business revenue composition includes: medical ultrasound 71.16%, industrial ultrasound 17.30%, accessories 5.72%, X-ray 4.56%, and others 1.26% [7]. - The company is classified under the pharmaceutical and biological industry, specifically in medical devices, and is recognized as a national key high-tech enterprise [7]. Group 2: Financial Performance - For the first half of 2025, the company achieved operating revenue of 184 million yuan, representing a year-on-year growth of 15.00%, and a net profit attributable to shareholders of 68.45 million yuan, with a year-on-year increase of 18.50% [8]. - As of June 30, 2025, the number of shareholders decreased by 16.65% to 22,300, while the average circulating shares per person increased by 19.98% to 2,456 shares [8]. - The company has distributed a total of 43.69 million yuan in dividends since its A-share listing [8]. Group 3: Market Dynamics - The company benefits from the depreciation of the RMB, with overseas revenue accounting for 55.26% of total revenue [3]. - The company participated in the 97th WVC annual meeting, showcasing innovations in veterinary medical imaging for pets, horses, and livestock, and gained valuable insights from industry experts [2]. Group 4: Technical Analysis - The average trading cost of the company's shares is 27.99 yuan, with recent accumulation activity noted, although the strength of this accumulation is weak [6]. - The current stock price is near a support level of 26.85 yuan, and if this support is breached, it may trigger a downward trend [6]. Group 5: Investment Sentiment - The stock experienced a decline of 2.68% on August 27, with a trading volume of 206 million yuan and a turnover rate of 12.85%, resulting in a total market capitalization of 11.514 billion yuan [1]. - The main capital flow showed a net outflow of 4.67 million yuan, indicating a reduction in main capital positions over three consecutive days [4][5].
超研股份跌2.68%,成交额2.06亿元,近3日主力净流入-3165.84万